Nurse Practitioner · Boston, MA
NPI
1235511031
Since 2015
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
800 Washington St
Boston, MA, 02111
Phone (617) 636-4809
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$456K
488 prescriptions
Company payments, 2025
$19.08
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Catherine G Carroll prescribed most often to Medicare patients was Metoprolol Succinate, with 91 prescriptions and refills. In total Catherine G Carroll wrote 488 Medicare prescriptions that cost $456K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-20.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Metoprolol Succinate Generic | 91 | 247 | 32 | $2,452 |
| Eliquis Apixaban | 70 | 134 | 17 | $76K |
| Verapamil Er Verapamil Hcl | 39 | 88 | 14 | $1,013 |
| Norpace Cr Disopyramide Phosphate | 35 | 53 | Under 11 | $14K |
| Camzyos Mavacamten | 35 | 35 | 12 | $293K |
| Jardiance Empagliflozin | 32 | 70 | 11 | $40K |
| Lisinopril Generic | 22 | 50 | Under 11 | $166 |
| Amlodipine Besylate Generic | 22 | 49 | 11 | $255 |
| Entresto Sacubitril/Valsartan | 18 | 26 | Under 11 | $17K |
| Atorvastatin Calcium Generic | 16 | 48 | Under 11 | $201 |
| Carvedilol Generic | 14 | 18 | Under 11 | $41.38 |
| Hydrochlorothiazide Generic | 14 | 40 | Under 11 | $32.18 |
Brand drugs: 202 claims; generic drugs: 286 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Catherine G Carroll $19.08 ($19.08 in general payments such as food, travel and fees) from 1 company. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $19.08.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $19.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.